Lumen Technologies
LUMN
5.91
+0.01
+0.08%
Lumen Technologies
US · LUMN
#1935 by market cap
Listed 1970
5.91
+0.01
+0.08%
Live - 5344 symbols - heartbeat 238s ago
· 2026-10-08 08:28
Pre-market
5.82
-1.46%
After-hours
5.90
-0.17%
- Market cap
- 6.10B
- P/E (TTM)i
- -5.74
- P/Bi
- -4.10
- EPSi
- -1.75
- Div yieldi
- 0.00%
- 52W posi
- 8%
Reader sentiment
Are you bullish or bearish on LUMN?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is -0.23, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -5.39% YoY
Margins
- Gross margin
- 46.48%
- Operating margin
- -1.48%
- Net margin
- -14.02%
Key ratios & quality
- Enterprise valuei
- 22.80B
- Altman Z-Scorei
- -0.23
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 22.58B | 21.46B | 20.71B | 19.69B | 17.48B | 14.56B | 13.11B | 12.40B |
| Gross profit | 12.58B | 12.32B | 11.78B | 11.20B | 9.61B | 7.41B | 6.41B | 5.76B |
| Selling & admin expenses | 4.17B | 3.72B | 3.46B | 2.90B | 3.08B | 3.20B | 2.97B | 3.20B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 3.30B | 3.78B | 3.60B | 4.29B | 3.29B | 1.23B | 477.00M | -184.00M |
| Pretax profit | -1.56B | -4.77B | -782.00M | 2.70B | -991.00M | -10.24B | -230.00M | -2.72B |
| Tax | 170.00M | 503.00M | 450.00M | 668.00M | 557.00M | 61.00M | -175.00M | -977.00M |
| Net profit | -1.73B | -5.27B | -1.23B | 2.03B | -1.55B | -10.30B | -55.00M | -1.74B |
| Basic EPS | -2 | -5 | -1 | 2 | -2 | -10 | 0 | -2 |
| Diluted EPS | -1.63 | -4.92 | -1.14 | 1.91 | -1.54 | -10.48 | -0.06 | -1.75 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 3.18B | 3.09B | 3.09B | 3.04B | 2.90B | 2.81B |
| Gross profit | 1.50B | 1.47B | 1.39B | 1.41B | 1.46B | 1.39B |
| Selling & admin expenses | 675.00M | 755.00M | 829.00M | 940.00M | 794.00M | 779.00M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 107.00M | 25.00M | -116.00M | -200.00M | 6.00M | -57.00M |
| Pretax profit | -245.00M | -1.15B | -813.00M | -509.00M | 177.00M | -255.00M |
| Tax | -44.00M | -234.00M | -192.00M | -507.00M | 377.00M | -54.00M |
| Net profit | -201.00M | -915.00M | -621.00M | -2.00M | -200.00M | -201.00M |
| Basic EPS | 0 | -1 | -1 | 0 | 0 | 0 |
| Diluted EPS | -0.20 | -0.92 | -0.62 | 0.00 | -0.20 | -0.20 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 3.82B | 4.77B | 3.18B | 11.54B | 5.45B | 4.78B | 4.39B | 7.91B |
| Cash & ST investments | 488.00M | 1.69B | 406.00M | 354.00M | 1.25B | 2.23B | 1.89B | 1.00B |
| Inventory | 120.00M | 105.00M | 105.00M | 96.00M | 236.00M | 209.00M | 146.00M | 165.00M |
| Total assets | 70.26B | 64.74B | 59.39B | 57.99B | 45.61B | 34.02B | 33.50B | 34.34B |
| Total current liabilities | 5.53B | 7.26B | 6.63B | 7.17B | 4.90B | 3.53B | 3.64B | 4.39B |
| Short-term debt | 652.00M | 2.72B | 2.81B | 1.94B | 498.00M | 425.00M | 665.00M | 354.00M |
| Long-term debt | 35.41B | 32.39B | 29.41B | 27.43B | 20.42B | 19.83B | 17.49B | 17.35B |
| Total liabilities | 50,428,000,000.00 | 51,272,000,000.00 | 48,232,000,000.00 | 46,153,000,000.00 | 35,238,000,000.00 | 33,601,000,000.00 | 33,032,000,000.00 | 35,459,000,000.00 |
| Total equity | 19.83B | 13.47B | 11.16B | 11.84B | 10.37B | 417.00M | 464.00M | -1.12B |
| Retained earnings | -1.64B | -6.81B | -8.03B | -6.00B | -7.61B | -17.91B | -17.96B | -19.70B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 4.28B | 7.74B | 8.71B | 7.91B | 4.12B | 4.11B |
| Cash & ST investments | 1.90B | 1.57B | 2.40B | 1.00B | 1.63B | 1.88B |
| Inventory | 124.00M | 126.00M | 163.00M | 165.00M | 132.00M | 122.00M |
| Total assets | 33.54B | 32.98B | 34.29B | 34.34B | 30.62B | 30.78B |
| Total current liabilities | 3.55B | 3.63B | 3.93B | 4.39B | 4.17B | 4.26B |
| Short-term debt | 593.00M | 606.00M | 367.00M | 354.00M | 325.00M | 345.00M |
| Long-term debt | 17.33B | 17.57B | 17.58B | 17.35B | 12.93B | 13.15B |
| Total liabilities | 33,249,000,000.00 | 33,571,000,000.00 | 35,459,000,000.00 | 35,459,000,000.00 | 31,939,000,000.00 | 32,270,000,000.00 |
| Total equity | 289.00M | -595.00M | -1.17B | -1.12B | -1.32B | -1.49B |
| Retained earnings | -18.16B | -19.08B | -19.70B | -19.70B | -19.90B | -20.10B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 7.03B | 6.68B | 6.52B | 6.50B | 4.74B | 2.16B | 4.33B | 4.74B |
| Depreciation & amortization | 5.12B | 4.83B | 4.71B | 4.02B | 3.24B | 2.99B | 2.96B | 2.75B |
| Free cash flow | 3.86B | 3.05B | 2.80B | 3.60B | 1.72B | -940.00M | 1.10B | 371.00M |
| Dividends paid | -2.31B | -1.10B | -1.11B | -1.09B | -780.00M | -11.00M | -3.00M | -1.00M |
| Stock buybacks / issuance | -- | 0 | 0 | -1.00B | -200.00M | -- | -- | -- |
| Ending cash balance | 518.00M | 1.72B | 427.00M | 409.00M | 1.31B | 2.25B | 1.90B | 1.01B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 1.10B | 570.00M | 2.51B | 562.00M | 1.32B | 971.00M |
| Depreciation & amortization | 713.00M | 688.00M | 674.00M | 674.00M | 664.00M | 668.00M |
| Free cash flow | 304.00M | -321.00M | 1.47B | -1.08B | 380.00M | 69.00M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 1.91B | 1.58B | 2.41B | 1.01B | 1.64B | 1.89B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -8.00 | -31.65 | -10.00 | 17.68 | -13.90 | -189.75 | -12.49 | -- |
| ROA %i | -2.38 | -7.81 | -1.98 | 3.46 | -2.99 | -25.87 | -0.16 | -5.13 |
| ROIC %i | -0.25 | -7.17 | -0.03 | 7.52 | -1.37 | -36.20 | 4.76 | -- |
| 5-year avg ROE %i | 2.98 | -4.30 | -7.51 | -4.89 | -9.18 | -45.75 | -41.92 | -- |
| EBIT margin %i | 2.62 | -12.25 | 4.28 | 21.45 | 1.95 | -62.37 | 8.71 | -11.55 |
| FCF / sales %i | 16.45 | 13.62 | 13.49 | 18.29 | 9.84 | -- | 8.41 | 2.99 |
| Current ratioi | 0.69 | 0.66 | 0.48 | 1.61 | 1.11 | 1.35 | 1.21 | 1.80 |
| Quick ratioi | 0.55 | 0.55 | 0.37 | 0.29 | 0.57 | 1.09 | 0.99 | 0.64 |
| Debt / assetsi | 51.33 | 54.23 | 54.24 | 50.64 | 45.86 | 59.54 | 54.21 | 51.56 |
| LT debt / equityi | 178.58 | 240.49 | 263.48 | 231.66 | 196.82 | 4,755.64 | 3,770.26 | -- |
| Interest coveragei | 0.28 | -1.36 | 0.53 | 2.77 | 0.26 | -7.84 | 0.83 | -1.12 |
| Revenue CAGR (3Y) %i | 8.05 | 7.09 | 5.47 | -4.47 | -6.61 | -11.09 | -12.68 | -10.81 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | 19.14 | 23.33 | 53.55 | -2.26 | -17.42 | -- | -32.61 | -40.02 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -78.94 | -- | -- | -- | -- | -- |
| ROA %i | -0.94 | -3.58 | -4.84 | -5.13 | -5.42 | -3.21 |
| ROIC %i | 3.98 | -- | -- | -- | -- | -- |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 6.55 | -2.28 | -7.60 | -11.55 | -9.34 | -3.17 |
| FCF / sales %i | 7.82 | 7.31 | 9.66 | 2.99 | 3.69 | 7.07 |
| Current ratioi | 1.21 | 2.13 | 2.21 | 1.80 | 0.99 | 0.96 |
| Quick ratioi | 0.98 | 0.90 | 1.05 | 0.64 | 0.78 | 0.77 |
| Debt / assetsi | 53.45 | 55.10 | 52.34 | 51.56 | 43.27 | 43.84 |
| LT debt / equityi | 5,997.92 | -- | -- | -- | -- | -- |
| Interest coveragei | 0.60 | -0.21 | -0.71 | -1.12 | -0.97 | -0.37 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Business is the largest reported line at 87.13% of revenue, across 2 reported segments.
- The next-largest line, Mass Markets, is a distant second at 12.87% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Business87.13%
Mass Markets12.87%
Quote time 2026-10-08 08:28:04 · For reference only, not investment advice and not tailored to your situation.